Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia
about
Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domainThe human Major Histocompatibility Complex as a paradigm in genomics researchRecent advances in the genetics of autoimmune diseaseRisk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.A novel BAT3 sequence generated by alternative RNA splicing of exon 11B displays cell type-specific expression and impacts on subcellular localization.Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis.Improved drug therapy: triangulating phenomics with genomics and metabolomics.Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locusSelective IgA deficiency in autoimmune diseasesGenetics of myasthenia gravis: a case-control association study in the Hellenic population.Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course.Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseasesThymoma and paraneoplastic myasthenia gravis.The thymus in myasthenia gravis: Site of "innate autoimmunity"?Reconsidering the association between the major histocompatibility complex and bipolar disorder.BAG6/BAT3: emerging roles in quality control for nascent polypeptides.BAG-6, a jack of all trades in health and disease.Recent advances in genetic predisposition of myasthenia gravis.Pervasive haplotypic variation in the spliceo-transcriptome of the human major histocompatibility complex.Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.Trans-species polymorphism, HLA-disease associations and the evolution of the MHC.Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.The immunogenetics of neurological disease.Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis.Prognostic factors and health-related quality of life in ocular Myasthenia Gravis (OMG).The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.Common immunogenetic profile in children with multiple autoimmune diseases: the signature of HLA-DQ pleiotropic genes.
P2860
Q24311324-6C49936B-EEA4-42CC-8013-4E0B1A792402Q24596895-51A3D3AF-6B2E-44C2-9C5C-12C5D6C6CD90Q28238782-A40BE9DC-4415-4240-AFF0-17C4399B105CQ28943379-31FC3D98-0E6F-446E-B88E-B21B81892EA1Q33942125-41F19099-1621-4F4E-A7C3-B29A5969A6E9Q34256996-7B84C2DB-AD86-4E66-9B30-7A3FED851F4CQ34270872-A42FDE9B-3889-4E82-BE1C-829B0353D76DQ34286801-C9F1A5F9-4106-4D3C-8927-C99A0B068397Q34436487-4A4FD68B-6836-49BD-AD85-A735C01B0FBFQ34756777-7A54107C-E3B8-4AB4-ABAD-0837CE1C2D9DQ35876782-C7281609-D784-4C51-8A83-9907E5FEF0CCQ36294292-DBBE7801-9172-4BBB-9BF6-5D8BF7BDB869Q37339780-EAD43C85-518D-48DE-A5C4-B0876E958BF9Q37413517-8CA17DF8-72E3-4913-A1A9-8D158B9EB9D7Q37727991-A3A129B5-E6A0-435A-9B15-08842C100CC1Q37933171-1805545A-043B-4FB9-A42D-8A1D46148372Q37944156-A7CD54E2-670F-4AEA-B0A6-0B955FE2B60EQ38070391-95AE53ED-55C1-4BFD-951D-0A1E84B27992Q38168708-CFA86A1F-E819-4AE0-A48C-F98CEF2C4800Q41953614-3506BB1D-DDB0-46F0-A270-AD5921F8666CQ42124676-50601A7D-6A8A-478C-9A08-EF2AA52A105DQ42155343-6F422F85-DDF9-42F9-933B-5BFEDC716D46Q42627268-D6FEA7F7-E6F5-4E82-A202-EDB13CB2FBC8Q42756349-3B18FA5D-FCBC-44CB-81EA-562FC360AA9FQ46094020-3C8B1E80-A3F0-41B5-99DF-51C9432D1E04Q47192132-4527A16F-F0E8-4B88-8A8E-9C2361F67BA9Q47442517-0952E096-1B68-4336-A622-DD56FAD20C5FQ48135299-A5074FF2-8083-49BF-852B-B49319E06760Q51111282-9C0A90C0-5E5A-47C6-9209-A6BDB3379A56Q51356348-D5D2A061-7A0A-4D7D-9671-57483BA9F55C
P2860
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@ast
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@en
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@nl
type
label
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@ast
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@en
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@nl
prefLabel
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@ast
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@en
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@nl
P2093
P2860
P50
P3181
P356
P1476
Pleiotropic effects of the 8.1 ...... gravis and thymus hyperplasia
@en
P2093
Bruno Eymard
Catherine Hue-Beauvais
Geneviève Beaurain
Henri-Jean Garchon
Philippe Gajdos
P2860
P304
P3181
P356
10.1073/PNAS.0406756101
P407
P577
2004-10-26T00:00:00Z